GlassScriptPhysician profile
Vivek Kumbhari
NPI 1740522069
$254,050.01
in general payments reported to CMS, 2019-2025
21 companies · $5,603 in 2025
The $5,603 reported for 2025 was more than what 91% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105K · 2020: $51K · 2021: $47K · 2022: $33K · 2023: $9,670 · 2024: $3,773 · 2025: $5,603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Consulting Fee: $4,000 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,000 · Food and Beverage: $2,697 · Travel and Lodging: $2,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Consulting Fee | $4,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,000.00 |
| Food and Beverage | $2,696.91 |
| Travel and Lodging | $2,349.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apollo Endosurgery US INC | $64,507.07 | 2019-2023 | Overstitch Endoscopic Suturing System |
| Fujifilm Healthcare Americas Corporation | $34,561.95 | 2019-2023 | Fujifilm |
| Erbe Elektromedizin Gmbh | $33,038.68 | 2021-2022 | |
| Pentax of America, INC. | $30,025.65 | 2019-2020 | |
| Covidien LP | $25,518.22 | 2019-2020 | |
| Boston Scientific Corporation | $20,446.09 | 2019-2025 | Exalt Model D, Resolution Clip, General - Biliary Devices |
| Medtronic, INC. | $18,517.67 | 2021-2025 | Gi Genius |
| Micro-Tech Endoscopy USA, INC. | $17,509.64 | 2021-2025 | Goldknife, Lockado, Repositionable Hemostasis Clip |
| Erbe USA INC | $4,891.34 | 2019 | |
| Cook Medical LLC | $2,058.84 | 2019-2024 | Echotip Insight |
| Olympus America INC. | $857.68 | 2019-2023 | Evis Exera II Ultrasound Gastrovideoscope |
| Intuitive Surgical, INC. | $450.00 | 2021 | |
| Endogastric Solutions, INC | $417.68 | 2019 | |
| Ambu INC. | $323.02 | 2020-2024 | |
| Gi Supply, INC. | $300.00 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Creo Medical INC. | $228.38 | 2022-2023 | Speedboat |
| Gyrus Acmi, INC. | $178.08 | 2025 | |
| Novo Nordisk INC | $60.63 | 2023 | |
| Laborie Medical Technologies Corp. | $60.61 | 2023 | |
| Olympus Corporation of The Americas | $57.94 | 2019-2025 | Single Use Electrosurgical Knife Kd-655 |
| Fujifilm New Development USA, INC. | $40.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Kumbhari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.